BioSpace News Archive

ArQule, Inc. today announced it will report financial results for the third quarter 2017 before the market opens on Thursday, November 9, 2017.

Antibe Therapeutics Inc.is pleased to announce that its subsidiary, Citagenix Inc., has been selected by Darby Dental Supply, LLC (“Darby Dental”) to be its supplier of premium bone grafting and tissue regeneration products.

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. , announced today that Chief Executive Officer Michael D. West, Ph.D., who also serves as Co- CEO of BioTime, is giving an interview as part of The Economist magazine’s conference.

Alkermes plc unveiled Aripiprazole Lauroxil NanoCrystal Dispersion (ALNCD), a novel, investigational product designed for initiation onto ARISTADA (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.

Alkermes plc today reported financial results for the third quarter of 2017.

-- Retrospective Analyses Compared H.P. Acthar® Gel (Repository Corticotropin Injection) with Non-Corticosteroid Treatments on MS Relapse, Unresolved Relapse, and Healthcare Resource Use -- [26-October-2017] STAINES-UPON-THAMES, United Kingdom, Oct. 26, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, ann

Dicerna Pharmaceuticals announced that the Company will release its third quarter 2017 financial results after market close on Thursday, November 2, 2017.

McKesson Corporation today reported that revenues for the second quarter ended September 30, 2017, were $52.1 billion, up 4% compared to $50.0 billion a year ago.

Celgene reduces its 2020 sales guidance to the range of $19 billion to $20 billion from its previous forecast of more than $21 billion.

Catabasis Pharmaceuticals today announced that CAT-5571, which restores host defense by activating autophagy, will be presented in a poster at the 31st Annual North American Cystic Fibrosis Conference (NACFC).